Infectious disease Archives

News and Trends 13 Nov 2015

Curetis Molecular Diagnostics IPO Exceeds Expectations

The Southern German Med-tech for infectious disease biotech, Curetis, has sold shares up to a value of €40M, which is 10 million above its initial target, despite a lower ranged Offer price. Curetis have developed a molecular diagnostics system for hospital acquired infections (such as MRSA and Pneumonia). Their Unyvero system is a piece of […]

November 13, 2015 - 2 minutesmins - By Dani Bancroft

seasonal influenza universal vaccine sanofi peptcell seek niaid nihr

News and Trends 12 Nov 2015

Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Sanofi Pasteur is the infectious disease division of the French Giant Sanofi, responsible for producing 1 Billion vaccine doses each year. Now they are looking to ‘evolve’ the vaccine R&D field, adapting their approach to find a broader spectrum defense against seasonal Influenza strains. However, the UK NIHR and PepTCell are also after the same […]

November 12, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 12 Nov 2015

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

I am still at the mRNA Convention in Berlin…and was invited for a second interview – this time with the ‘RNA People’, battling to be the first to get an mRNA Drug onto the Worldwide Market. I had a chat with Franz-Werner Haas, the Chief Corporate Office of CureVac. We talked a lot about this […]

November 12, 2015 - 1 minutemin - By Philip Hemme

News and Trends 9 Nov 2015

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

Approved drugs can always show bad signs once injected massively. Four physicians from Paris sent a letter to the New England Journal of Medicine to report that Gilead’s Hepatitis C blockbuster drug, Sovaldi, can cause abnormally slower heart rates and risks of Heart Failure… The French Physicians report used data based on 415 patients treated […]

November 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 3 Nov 2015

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

“The RNA People” at CureVac in Tübingen (Germany) have a new €100M investment into their RNA platform, which has prophylactic purposes for common viruses, pipeline candidates for prostate cancer, lung cancer and research into vaccines for HIV, Tuborculosis and Rabies. Indeed, the financial success surrounding their mRNA work has been startlingly impressive, with the EU […]

November 3, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Oct 2015

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Bath, in South West England, has a lot more besides its historic beauty…The Jenkins Chemistry lab at the University of Bath has a fair few innovative solutions to the problem of infectious disease detection. Their latest design is a burns dressing which glows when a pathogenic biofilm is detected (as part of the Bacteriosafe Project) […]

October 28, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 27 Oct 2015

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

The Belgian biomanufacturing company Univercells and the Japanese pharmaceutical company Takeda have signed a strategic partnership agreement. Univercells has closed a €3M equity investment with Takeda Ventures to produce affordable vaccines. Univercells provides single-use cost-efficient bioprocess solutions to lead the next generation in biomanufacturing. Under the terms of the agreement, the two biotechs will launch a […]

October 27, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 14 Oct 2015

Curetis IPO Launched to further expand Infectious Disease Detection in Global Market

Curetis AG, the molecular diagnostics company from the Stuttgart area (Germany), has now announced its launch of an initial public offering (IPO). Previously, this biotech has raised €63.5M to develop its Unyvero Platform for testing infectious disease, including Pneumonia and biomarkers in antibiotic resistance. This new IPO aims to further commercialize this system and expand […]

October 14, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 5 Oct 2015

Medicine Nobel Prize for Parasite Drug Discoveries which saved Billions

The Nobel Prize for Medicine and Physiology has been jointly awarded to Youyou Tu (the first ever Chinese recipient of a Nobel Prize in this category) for discovering the malarial medicine Artemisinin, and to William C. Campbell and Satoshi Ōmura, for their pioneering work in developing a major parasitic round worm disease drug, Ivermectin. These […]

October 5, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 29 Sep 2015

A Cartridge system to revolutionize diagnosis time of infective pathogens?

Canada’s Axela partners up with Swiss Hutman Diagnostics to test the cartridge based detection kit with their pan-European infectious disease resources. The Alena System could revolutionize time and cost of diagnosing bacterial pathogens in meningitis, endocarditis and hospital-acquired infections etc. Hutman Diagnostics is originally from Basel (Switzerland) having been founded in 2011 as a developer […]

September 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 25 Sep 2015

This week’s major stories outside the EU you NEED to read! (Martin Shkreli, Biolimb, OrbiMed)

Happy Saturday everyone! This week was full of so many good articles, we’re doing a top 7 top stories outside the EU you need to know! Yes, you heard correctly, seven of the best articles for your reading pleasure, you are most welcome ;). THE CEO WHO JACKED UP THE PRICE OF A DRUG BY 5000% […]

September 25, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 17 Sep 2015

France’s leading Female Bio-entrepreneur joins board of Abivax

Dominique Costantini is one of France’s leading biotech figures, with over 20 years experience on boards, partnerships and business backing in some of the biotech industries leading brands. With a medical background specializing in immunology (from Paris V University), Costantini co-founded oncology focused Onxeo in 1997. Formerly known as BioAlliance Pharma, this biotech went public […]

September 17, 2015 - 2 minutesmins - By Dani Bancroft

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Infectious disease

Curetis Molecular Diagnostics IPO Exceeds Expectations

Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries

Curetis IPO Launched to further expand Infectious Disease Detection in Global Market

Medicine Nobel Prize for Parasite Drug Discoveries which saved Billions

A Cartridge system to revolutionize diagnosis time of infective pathogens?

This week’s major stories outside the EU you NEED to read! (Martin Shkreli, Biolimb, OrbiMed)

France’s leading Female Bio-entrepreneur joins board of Abivax

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!